JP2011507497A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507497A5
JP2011507497A5 JP2010538788A JP2010538788A JP2011507497A5 JP 2011507497 A5 JP2011507497 A5 JP 2011507497A5 JP 2010538788 A JP2010538788 A JP 2010538788A JP 2010538788 A JP2010538788 A JP 2010538788A JP 2011507497 A5 JP2011507497 A5 JP 2011507497A5
Authority
JP
Japan
Prior art keywords
her2 binding
binding polypeptide
amino acid
polypeptide
polypeptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010538788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507497A (ja
JP5913807B2 (ja
Filing date
Publication date
Priority claimed from EP07150395A external-priority patent/EP2072525A1/en
Application filed filed Critical
Publication of JP2011507497A publication Critical patent/JP2011507497A/ja
Publication of JP2011507497A5 publication Critical patent/JP2011507497A5/ja
Application granted granted Critical
Publication of JP5913807B2 publication Critical patent/JP5913807B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010538788A 2007-12-21 2008-12-22 Her2に対する親和性を有する新規なポリペプチド Active JP5913807B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07150395A EP2072525A1 (en) 2007-12-21 2007-12-21 New polypeptides having affinity for HER2
EP07150395.7 2007-12-21
PCT/EP2008/068167 WO2009080810A1 (en) 2007-12-21 2008-12-22 New polypeptides having affinity for her2

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014211333A Division JP2015061838A (ja) 2007-12-21 2014-10-16 Her2に対する親和性を有する新規なポリペプチド

Publications (3)

Publication Number Publication Date
JP2011507497A JP2011507497A (ja) 2011-03-10
JP2011507497A5 true JP2011507497A5 (enExample) 2012-01-19
JP5913807B2 JP5913807B2 (ja) 2016-04-27

Family

ID=39148791

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010538788A Active JP5913807B2 (ja) 2007-12-21 2008-12-22 Her2に対する親和性を有する新規なポリペプチド
JP2014211333A Pending JP2015061838A (ja) 2007-12-21 2014-10-16 Her2に対する親和性を有する新規なポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014211333A Pending JP2015061838A (ja) 2007-12-21 2014-10-16 Her2に対する親和性を有する新規なポリペプチド

Country Status (11)

Country Link
US (2) US8501909B2 (enExample)
EP (2) EP2072525A1 (enExample)
JP (2) JP5913807B2 (enExample)
CN (2) CN104327179A (enExample)
AU (1) AU2008339976B2 (enExample)
CA (1) CA2709915C (enExample)
DK (1) DK2235044T3 (enExample)
ES (1) ES2440919T3 (enExample)
HK (1) HK1202880A1 (enExample)
PL (1) PL2235044T3 (enExample)
WO (1) WO2009080810A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9187535B2 (en) 2007-12-19 2015-11-17 Affibody Ab Polypeptide derived from protein A and able to bind PDGF
EP2077272A1 (en) 2007-12-21 2009-07-08 Affibody AB Polypeptide libraries with a predetermined scaffold
EP2072525A1 (en) * 2007-12-21 2009-06-24 Affibody AB New polypeptides having affinity for HER2
KR101671537B1 (ko) 2008-08-11 2016-11-01 넥타르 테라퓨틱스 다분지형 중합체 알카노에이트 컨쥬게이트
US20120165650A1 (en) * 2010-12-22 2012-06-28 General Electric Company Her2 binders
WO2010120514A2 (en) * 2009-03-31 2010-10-21 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
EP2496598B1 (en) 2009-11-04 2017-08-02 Affibody AB Her3 binding polypeptides
WO2011110515A1 (en) * 2010-03-08 2011-09-15 Affibody Ab Immunoglobulin g fc region binding polypeptide
DE102010026061A1 (de) 2010-06-30 2012-01-05 Siemens Aktiengesellschaft 11C-markiertes Peptid zur Detektion eines Tumors, der einen Her2/neu-Rezeptor exprimiert
TWI486617B (zh) * 2010-10-21 2015-06-01 Iner Aec Executive Yuan 一種測定對鎝(Tc-99m)與錸(Re-186、Re-188)具有穩定錯合力之含硫螯合劑在凍晶劑中之含量與均一性的固態樣品分析技術
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
EP2654803B1 (en) * 2010-12-22 2021-08-18 General Electric Company Radiolabeled her2-binding peptide conjugates
US9061080B2 (en) 2010-12-22 2015-06-23 Ge Healthcare Limited HER2 binding peptides labeled with aluminium-[18] fluoride complexed by NOTA
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
NZ612327A (en) * 2010-12-22 2015-03-27 Ge Healthcare Ltd Her2 binding peptides labelled with a 18f - containing organosilicon compound
CN102690345B (zh) * 2011-03-24 2014-03-19 江苏靶标生物医药研究所有限公司 人膜联蛋白v变体及其表达、制备和应用
WO2012166555A1 (en) 2011-05-27 2012-12-06 Nektar Therapeutics Water - soluble polymer - linked binding moiety and drug compounds
KR102149028B1 (ko) 2012-02-20 2020-08-27 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) 인간 보체 c5에 결합하는 폴리펩티드
WO2014013016A1 (en) 2012-07-20 2014-01-23 Affibody Ab Method for determining the her2 status of a malignancy
WO2014053586A1 (en) * 2012-10-05 2014-04-10 Affibody Ab Her3 binding polypeptides
WO2014076179A1 (en) 2012-11-14 2014-05-22 Affibody Ab New polypeptide
KR20160055728A (ko) * 2013-06-27 2016-05-18 지이 헬쓰케어 리미티드 Her2 결합제의 용도
US9982022B2 (en) * 2013-08-28 2018-05-29 Affibody Ab Binding polypeptides having a mutated scaffold
WO2015028558A1 (en) 2013-08-28 2015-03-05 Swedish Orphan Biovitrum Ab (Publ) Stable polypeptides binding to human complement c5
ES2864124T3 (es) 2014-03-11 2021-10-13 Molecular Templates Inc Proteínas que comprenden regiones de unión, regiones efectoras de la subunidad A de toxina Shiga y motivos señal de localización de retículo endoplasmático carboxi terminal
PT3604333T (pt) 2014-03-11 2021-06-07 Molecular Templates Inc Proteínas compreendendo regiões efetoras da subunidade a da toxina shiga próximas de amino-terminais e regiões de ligação do tipo imunoglobulina de direcionamento celular capazes de se ligarem especificamente a cd38
CN104292308B (zh) * 2014-08-22 2017-09-15 广州安辰医药科技有限公司 肿瘤抗原环肽
PL3212225T3 (pl) 2014-10-31 2026-03-30 The Trustees Of The University Of Pennsylvania Sposoby i kompozycje zmodyfikowanych limfocytów t
WO2016086036A2 (en) 2014-11-25 2016-06-02 Bristol-Myers Squibb Company Methods and compositions for 18f-radiolabeling of biologics
JP6622814B2 (ja) * 2014-11-25 2019-12-18 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company イメージングのための新規pd−l1結合ポリペプチド
CN114656573B (zh) 2015-05-30 2024-09-27 分子模板公司 去免疫化的志贺毒素a亚基支架和包含它们的细胞靶向分子
MX2018001208A (es) 2015-07-26 2018-03-26 Molecular Templates Inc Moleculas con direccion a las celulas que comprenden efectores de la subunidad a de la toxina shiga y epitopos de celulas-t cd8+.
CN109562195A (zh) 2016-06-01 2019-04-02 百时美施贵宝公司 用pd-l1结合多肽进行pet成像
WO2017210335A1 (en) 2016-06-01 2017-12-07 Bristol-Myers Squibb Company Imaging methods using 18f-radiolabeled biologics
KR102590672B1 (ko) 2017-01-25 2023-10-18 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 이펙터 및 cd8+ t-세포 에피토프를 포함하는 세포-표적화 분자
KR20200143634A (ko) 2018-04-17 2020-12-24 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 스캐폴드를 포함하는 her2-표적화 분자
WO2021122729A1 (en) 2019-12-18 2021-06-24 Bracco Imaging Spa Anti-her2 polypeptides derivatives as new diagnostic molecular probes
CN114829388B (zh) * 2019-12-18 2026-02-03 伯拉考成像股份公司 抗her2多肽衍生物作为新的诊断分子探针
EP3842452A1 (en) 2019-12-26 2021-06-30 Universitat Autònoma de Barcelona Scaffold proteins and therapeutic nanoconjugates based on nidogen
CN112220931B (zh) * 2020-10-16 2022-03-08 上海交通大学 用于肿瘤主动靶向治疗的亲和体-细胞毒素偶联物及其纳米颗粒、制备方法、应用
WO2022171892A1 (en) 2021-02-15 2022-08-18 Affibody Ab New her2-binding polypeptide
CN112999369B (zh) * 2021-03-03 2022-02-25 江苏元本生物科技有限公司 一种her2亲合体放射性核素标记物组合物及其应用
CN116063397B (zh) * 2022-07-04 2025-05-02 中国药科大学 一类靶向her2蛋白的多肽及其在制备多肽偶联药物中的应用
CN117430670A (zh) * 2022-07-20 2024-01-23 中国科学院上海药物研究所 一种her2靶向肽分子及其应用
CN119677787A (zh) 2022-08-10 2025-03-21 兴和株式会社 亲和体微胞药物复合体
WO2025158010A1 (en) 2024-01-25 2025-07-31 Affibody Ab Her2-binding polypeptide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
SE0301987D0 (sv) * 2003-07-04 2003-07-04 Affibody Ab New polypeptide
CA2531238C (en) * 2003-07-04 2015-02-24 Affibody Ab Polypeptides having binding affinity for her2
GB0524788D0 (en) * 2005-12-05 2006-01-11 Affibody Ab Polypeptides
US8937047B2 (en) 2007-12-19 2015-01-20 General Electric Company Biokinetics of fast-clearing polypeptides
US8124725B2 (en) 2007-12-19 2012-02-28 General Electric Company PDGF-Rβ binders
EP2077272A1 (en) 2007-12-21 2009-07-08 Affibody AB Polypeptide libraries with a predetermined scaffold
ES2373832T3 (es) 2007-12-19 2012-02-09 Affibody Ab Polipéptido derivado de proteína a y capaz de unirse a pdgf.
EP2072525A1 (en) * 2007-12-21 2009-06-24 Affibody AB New polypeptides having affinity for HER2

Similar Documents

Publication Publication Date Title
Sarko et al. Bifunctional chelators in the design and application of radiopharmaceuticals for oncological diseases
ES2615805T3 (es) Conjugados de antagonista de péptido análogo de la bombesina
Schweinsberg et al. Novel glycated [99mTc (CO) 3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors
JP6562838B2 (ja) Grpr陽性ガンの診断画像及び治療適用のための放射標識したgrprアンタゴニスト
Jackson et al. 64Cu-NO2A-RGD-Glu-6-Ahx-BBN (7-14) NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer
WO2019075583A1 (en) NOVEL RADIOMETAL BINDING COMPOUNDS FOR THE DIAGNOSIS OR TREATMENT OF CANCER EXPRESSING A PROSTATE-SPECIFIC MEMBRANE ANTIGEN
JP7502801B2 (ja) ガストリン放出ペプチド受容体(grpr)のインビボイメージングおよびgrpr関連障害の治療のための放射性標識ボンベシン由来化合物
US20220218852A1 (en) Novel radiolabelled cxcr4-targeting compounds for diagnosis and therapy
CN102316903A (zh) Pdgf-rbeta结合剂
CA3249424A1 (en) Compounds targeting CXCR4, and their manufacturing and use processes
US20250195702A1 (en) Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders
CA2485339C (en) Radiopharmaceutical formulations
JP2022537946A (ja) 化合物及びそれらの使用方法
US10471162B2 (en) Collagen targeted imaging probes
CA2464002C (en) Pacap compositions and methods for tumor imaging and therapy
Huo et al. Noninvasive PET imaging of a Ga-68-radiolabeled RRL-derived peptide in hepatocarcinoma murine models
JP7864129B2 (ja) 新規her2結合ポリペプチド
US20240189461A1 (en) Humanised antibodies labelled with radionuclides that emit beta-rays
ES2846023T3 (es) Agonistas selectivos del receptor de glucagón que comprenden un resto quelante para formación de imágenes
Okarvi Synthesis, radiolabeling and in vitro and in vivo characterization of a technetium‐99m‐labeled alpha‐M2 peptide as a tumor imaging agent
CN103330951B (zh) 一种新型vq多肽放射性药物及其制备方法
EP2328622B1 (en) Radiolabelled annexins
Erfani et al. New freeze-dried kit for diagnosis of Bombesin receptor expressing tumors